Trade

with

ARCA biopharma Inc
(NASDAQ: ABIO)
AdChoices
1.13
+0.03
+2.73%
After Hours :
-
-
-

Open

1.10

Previous Close

1.10

Volume (Avg)

288.68k (204.67k)

Day's Range

1.02-1.14

52Wk Range

1.02-2.54

Market Cap.

23.74M

Dividend Rate ( Yield )

-

Beta

2.31

Shares Outstanding

21.01M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 0

    • Net Income

    • -6.94M

    • Market Cap.

    • 23.74M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 2.31

    • Forward P/E

    • -2.31

    • Price/Sales

    • -

    • Price/Book Value

    • 1.23

    • Price/Cash flow

    • -2.10

      • EBITDA

      • -6.91M

      • Return on Capital %

      • -45.80

      • Return on Equity %

      • -48.09

      • Return on Assets %

      • -45.80

      • Book Value/Share

      • 0.92

      • Shares Outstanding

      • 21.01M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 3.75

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -0.49

        • Cashflow Estimate

        • -0.46

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -

            • 82.75

            • Pre-Tax Margin

            • -

            • 39.38

            • Net Profit Margin

            • -

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 16.17

              • 2.92

              • Quick Ratio

              • 15.92

              • 2.35

              • Interest Coverage

              • -3,153.33

              • 38.02

              • Leverage Ratio

              • 1.06

              • 2.21

              • Book Value/Share

              • 0.92

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -2.00

                • 243.90

                • P/E Ratio 5-Year High

                • -97.05

                • 634.30

                • P/E Ratio 5-Year Low

                • -1.91

                • 124.82

                • Price/Sales Ratio

                • -

                • 9.29

                • Price/Book Value

                • 1.24

                • 8.39

                • Price/Cash Flow Ratio

                • -2.10

                • 49.75

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -48.09

                        (-88.40)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -45.80

                        (-74.60)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -48.08

                        (-88.50)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • -

                      • 1.48

                      • Asset Turnover

                      • -

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -6.94M
                      Operating Margin
                      -
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -2.10
                      Ownership

                      Institutional Ownership

                      13.47%

                      Top 10 Institutions

                      16.15%

                      Mutual Fund Ownership

                      2.69%

                      Float

                      71.28%

                      5% / Insider Ownership

                      3.45%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Total Stock Mkt Idx

                      •  

                        320,424

                      • 0.00

                      • 1.54

                      • Bridgeway Ultra Small Company Fund

                      •  

                        120,000

                      • 0.00

                      • 0.57

                      • Vanguard Instl Total Stock Market Index

                      •  

                        69,700

                      • 0.00

                      • 0.33

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        25,653

                      • 0.00

                      • 0.12

                      • Vanguard Extended Market Index Fund

                      •  

                        14,128

                      • 0.00

                      • 0.07

                      • USAA Extended Market Index Fund

                      •  

                        10,074

                      • 83.60

                      • 0.05

                      • AXA/Lord Abbett Micro Cap Portfolio

                      •  

                        3,032

                      • 0.00

                      • 0.01

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Sabby Management LLC

                      •  

                        1,565,989

                      • +392.08%

                      • 9.98

                      • Vanguard Group, Inc.

                      •  

                        400,146

                      • +3.20%

                      • 1.90

                      • Bridgeway Capital Management, Inc

                      •  

                        120,000

                      • 0.00%

                      • 0.57

                      • Columbia Management Company

                      •  

                        64,620

                      • 0.00%

                      • 0.31

                      • Knight Capital Americas LLC

                      •  

                        48,786

                      • -32.30%

                      • 0.23

                      • Geode Capital Management, LLC

                      •  

                        25,653

                      • 0.00%

                      • 0.12

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Slow Growth

                      Style

                      Small Value

                      ARCA biopharma Inc is a development stage biopharmaceutical company. The Company is engaged in developing genetically-targeted therapies for cardiovascular diseases. Its product candidate is Gencaro.

                      Key People

                      Dr. Michael R. Bristow,M.D.,PhD

                      CEO/Director/President

                      Mr. Robert E. Conway

                      Director/Chairman of the Board

                      Mr. Patrick Wheeler

                      CFO/Chief Accounting Officer

                      Daniel J. Mitchell

                      Director

                      Dr. Linda Grais,M.D.

                      Director

                      • ARCA biopharma Inc

                      • 11080 CirclePoint Road

                      • Westminster, CO 80020

                      • USA.Map

                      • Phone: +1 720 940-2200

                      • Fax: +1 720 208-9261

                      • arcabiopharma.com

                      Incorporated

                      1992

                      Employees

                      14

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: